BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2956420)

  • 1. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
    Horwitz DA; Linker-Israeli M; Gray JD; Lemoine C
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():49-52. PubMed ID: 2956420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective loss of the CD4+ inducers of suppressor T cell subsets (2H4+) in active systemic lupus erythematosus.
    Raziuddin S; Nur MA; Alwabel AA
    J Rheumatol; 1989 Oct; 16(10):1315-9. PubMed ID: 2530345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell subsets in patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ
    Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
    Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
    J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of antibody secreting cells generated in the autologous mixed leukocyte reaction in man.
    Gatenby PA; Engleman EG
    Behring Inst Mitt; 1983 May; (72):143-52. PubMed ID: 6152687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations.
    Bass HZ; Yamashita N; Clement LT
    J Immunol; 1993 Sep; 151(6):2895-903. PubMed ID: 8376760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
    Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE.
    Surányi P; Mátyus L; Sonkoly I; Szegedi G
    Clin Exp Immunol; 1984 Oct; 58(1):37-41. PubMed ID: 6236918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte subsets and antilymphocyte antibodies in lupus nephritis.
    Patel R; Patel DR; Najera D
    Clin Nephrol; 1986 Aug; 26(2):83-6. PubMed ID: 2944680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus.
    Linker-Israeli M; Gray JD; Quismorio FP; Horwitz DA
    Clin Exp Immunol; 1988 Aug; 73(2):236-41. PubMed ID: 2972425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus.
    Dau PC; Callahan J; Parker R; Golbus J
    J Rheumatol; 1991 Feb; 18(2):270-6. PubMed ID: 1827161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
    Huang YP; Miescher PA; Zubler RH
    J Immunol; 1986 Dec; 137(11):3515-20. PubMed ID: 2946762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isolation and characterization of the human suppressor inducer T cell subset.
    Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
    J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.